Search results
Results from the WOW.Com Content Network
The stock’s rock-solid dividend and its growth potential from a number of positive wins suggest GSK stock will still climb higher. GlaxoSmithKline Is More Than Just a 5% Dividend Income Play ...
LONDON -- The shares of GlaxoSmithKline (ISE: GSK.L) (NYS: GSK) slid 9 pence to 1,411 pence during lunchtime London trade today despite the pharmaceutical group announcing a 6% lift to its ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
For premium support please call: 800-290-4726 more ways to reach us
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
This page was last edited on 23 January 2025, at 14:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies transferring their HIV assets to the new company. [1] In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. [ 2 ]